These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 4382839)
1. The use of perphenazine syrup in the severely disturbed mentally retarded child. Kaplitz SE IMJ Ill Med J; 1966 Dec; 130(6):785-7. PubMed ID: 4382839 [No Abstract] [Full Text] [Related]
6. Pharmacologic control of aberrant behavior in the mentally retarded: toward a more rational approach. Baumeister AA; Sevin JA Neurosci Biobehav Rev; 1990; 14(3):253-62. PubMed ID: 2234605 [TBL] [Abstract][Full Text] [Related]
7. Fluphenazine ("anatensol") in the treatment of disturbed mentally retarded children. Arnold E; Maginn DW Med J Aust; 1967 Apr; 1(15):758-60. PubMed ID: 6024150 [No Abstract] [Full Text] [Related]
8. A double-blind study comparing haloperidol with thioridazine in emotionally disturbed, mentally retarded children. Ucer E; Kreger KC Curr Ther Res Clin Exp; 1969 May; 11(5):278-83. PubMed ID: 4977399 [No Abstract] [Full Text] [Related]
9. Nortriptyline HCl as a tranquilizer for disturbed mentally retarded patients: a controlled study. Carter CH Am J Med Sci; 1966 Apr; 251(4):465-7. PubMed ID: 5910229 [No Abstract] [Full Text] [Related]
10. Haloperidol in the treatment of behavioural disorders in children and adolescents. Le Vann LJ Can Psychiatr Assoc J; 1969 Apr; 14(2):217-20. PubMed ID: 5783784 [No Abstract] [Full Text] [Related]
11. Intramuscular perphenazine for the treatment of disturbed behavior. Ritter RM; Jaquith WL; Nail HR; Head JJ J Miss State Med Assoc; 1968 Nov; 9(11):532-3. PubMed ID: 5722887 [No Abstract] [Full Text] [Related]
12. Social performance of the mentally retarded. Dingman HF Monogr Am Assoc Ment Defic (1973); 1973; (1):87-90. PubMed ID: 4806620 [No Abstract] [Full Text] [Related]
13. Appropriate use of psychic drugs in school children. Browder JA Am J Dis Child; 1972 Oct; 124(4):606-7. PubMed ID: 5080691 [No Abstract] [Full Text] [Related]
14. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability. Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758 [TBL] [Abstract][Full Text] [Related]
15. Medication compliance protocol for pediatric patients with severe intellectual and behavioral disabilities. Epitropakis C; DiPietro EA J Pediatr Nurs; 2015; 30(2):329-32. PubMed ID: 25193686 [TBL] [Abstract][Full Text] [Related]
16. New help for the severely retarded and emotionally disturbed child. Arje FB; Berryman DL J Rehabil; 1966; 32(1):14-5 passim. PubMed ID: 4221567 [No Abstract] [Full Text] [Related]
17. [Experiences with psychopharmaceutic agents in mentally retarded children]. Dosen A Tijdschr Kindergeneeskd; 1982 Feb; 50(1):10-9. PubMed ID: 6124053 [TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. Le Vann LJ Am J Ment Defic; 1971 May; 75(6):719-23. PubMed ID: 4932179 [No Abstract] [Full Text] [Related]
19. A clinical evaluation of mesoridazine in mentally retarded patients. Zaleski W Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609 [No Abstract] [Full Text] [Related]
20. Reduction of disruptive mealtime behavior by facial screening. A case study of a mentally retarded girl with long-term follow-up. Horton SV Behav Modif; 1987 Jan; 11(1):53-64. PubMed ID: 3508375 [No Abstract] [Full Text] [Related] [Next] [New Search]